Literature DB >> 7520267

No TP53 mutations in neuroblastomas detected by PCR-SSCP analysis.

J S Castresana1, M J Bello, J A Rey, P Nebreda, A Queizán, P García-Miguel, A Pestaña.   

Abstract

We have analysed 29 neuroblastomas for TP53 mutations in exons 5 to 8 by means of the polymerase chain reaction in combination with the single-strand conformation polymorphism technique. We could not detect any mutation. These results indicate that, in contrast to the majority of tumors so far studied, TP53 mutations do not seem to be important for the development of neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520267     DOI: 10.1002/gcc.2870100209

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.

Authors:  S C Goldman; C Y Chen; T J Lansing; T M Gilmer; M B Kastan
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

2.  Prognostic significance of the proliferative activity in neuroblastoma.

Authors:  P Rudolph; T Lappe; B Hero; F Berthold; R Parwaresch; D Harms; D Schmidt
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

3.  WIP1 phosphatase as a potential therapeutic target in neuroblastoma.

Authors:  Mark Richter; Tajhal Dayaram; Aidan G Gilmartin; Gopinath Ganji; Sandhya Kiran Pemmasani; Harjeet Van Der Key; Jason M Shohet; Lawrence A Donehower; Rakesh Kumar
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

4.  p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.

Authors:  Lindi Chen; Deborah A Tweddle
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

5.  Occurrence of Neuroblastoma among TP53 p.R337H Carriers.

Authors:  Ana Luiza Seidinger; Fernanda Paschoal Fortes; Maria José Mastellaro; Izilda Aparecida Cardinalli; Lilian Girotto Zambaldi; Simone Santos Aguiar; José Andrés Yunes
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.